BRIGHT-4: Large, 'Clean' Trial Clarifies Bivalirudin Benefits in STEMI

Experts say it’s likely too late for cath labs to stomach a bolus plus infusion, having turned back to heparin once and for all.

Related Keywords

China ,Munich ,Bayern ,Germany ,New York ,United States ,Paris ,France General ,France ,Shenyang ,Liaoning ,Chicago ,Illinois ,American ,Adnan Kastrati ,Yaling Han ,Philippe Gabriel Steg ,Deutsches Herzzentrum ,American Heart Association ,General Hospital ,Northern Theater Command ,Gregg Stone ,Icahn School ,Mount Sinai ,Rod Stables ,Liverpool Heart ,Chest Hospital ,Assistance Publique H ,Nail Out ,